Latest News Archive

Please select Category, Year, and then Month to display items
Categories
UFS News Media Release Research
Years
2017 2018 2019 2020 2021 2022 2023 2024
Months
January February March April May June July August September October November December
Previous Archive
20 March 2018 Photo Charl Devenish
Town and Gown programme to expand university reach in communities
Prof Petersen signs an MOU with Princess Motshabi Moroka, patron of the Princess Gabo Foundation, at the launch of the Town and Gown programme.
The University of the Free State (UFS), through the office of Community Engagement, launched the Town and Gown programme on 13 March 2018 at the Bloemfontein Campus. The programme seeks to demonstrate the university’s commitment to building sustainable partnerships in communities and its surrounding towns. It aims to be integrally involved in addressing societal challenges, as well as to avail its intellectual and academic resources to partner with civic and religious organisations, government entities and business communities.

Engaged scholarship central to institutional strategy
In his welcoming remarks, Prof Nicky Morgan Acting Vice Rector: Institutional Change and Student Affairs, said: “The university is not complete without its community and in the same way the community should benefit from the university. This has been encompassed in the newly launched Integrated Transformation Plan (ITP) which has community engagement as one of its components.”  The event was attended by representatives of the Mangaung Metropolitan Municipality, NGOs, religious and traditional leaders, student structures and UFS staff members.

Prof Francis Petersen: Rector and Vice Chancellor, said the university ought to articulate community engagement differently from what other organisations would do, by showcasing engaged scholarship and using teaching and research to make a difference. He emphasised the importance of being close enough to communities to be able to ascertain their needs in such a way that the component of community is brought into the classroom and in the university’s research.

Expansion of community outreach under way
The long-standing ties between the university and communities in the Free State span many years, during which time various collaborative projects have been established with, among others, Non Profit Organisations (NPOs), such as Bloemshelter, faith-based organisations, and traditional leadership structures.

To date, the UFS has supported programmes in education, health, law and rural development through service-learning programmes, involving students and academics in various fields. The target of the Town and Gown programme is to reach out further to include new partnerships in the Motheo Metro Municipality, Maluti-a-Phofung District Municipality, and Kopanong Local Municipality.

Long-standing partnerships strengthened
At the event, several memoranda of understanding (MOU) were signed to confirm five-year collaborative agreements between the university and partner organisations, one of which is the Princess Gabo Foundation based in Thaba Nchu. Bishop Billyboy Ramahlele, Director: Community Engagement said that the MOUs would strengthen partnership with the communities in research, community service learning, and volunteer programmes.

The Town and Gown initiative is a step taken to re-affirm the university’s commitment to partnering with stakeholders in strengthening the capacity of surrounding towns, metros and the Free State region as a whole.

News Archive

Nuclear Medicine on the forefront of cancer research
2017-07-10

Description: Nuclear Medicine on the forefront of cancer research Tags: Nuclear Medicine, cancer research, Dr Je’nine Horn-Lodewyk’s, tumour detection method, cancer, Department of Nuclear Medicine 

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma.  The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept